Kimpton M, Cerquozzi S, Toupin D, Ianotto J-C, Villleneuve P, Siegal DM, Carrier M, Delluc A. Breaking barriers in rare disease research: a pilot trial of thromboprophylaxis with apixaban versus aspirin in JAK2-Positive myeloproliferative neoplasms. haematol [Internet]. 2020Sep.10 [cited 2026May9];. Available from: https://haematologica.org/article/view/14172